Ibritumomab (Anti-CD20)
Ibritumomab (anti-CD20) is a monoclonal antibody targeting anti-CD20 used to treat B-cell non-Hodgkin's lymphoma. MW: 144.52 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2896 |
| Sku # | A2896-1mg |
| Pricing | 1mg, $539.00 |